Zinc lozenges reduce the duration of common cold symptoms

Nutrition Reviews

Abstract

A randomized, double-blind, placebo-controlled clinical trial has shown that treatment of the common cold with zinc gluconate lozenges resulted in a significant reduction in duration of symptoms of the cold. Patients received zinc-containing lozenges or placebo lozenges every 2 hours for the duration of cold symptoms. The median time to complete resolution of cold symptoms was 4.4 days in the zinc group compared with 7.6 days in the placebo group. The mechanism of action of zinc in treating the common cold remains unknown.

References

Jun 1, 1992·The Journal of International Medical Research·J C GodfreyN J Godfrey
May 1, 1989·Antimicrobial Agents and Chemotherapy·D S SmithA Magner
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·J C Godfrey
Apr 1, 1988·Antimicrobial Agents and Chemotherapy·G A Eby
Dec 1, 1987·The Journal of Antimicrobial Chemotherapy·W Al-NakibD A Tyrrell
Dec 1, 1986·The American Journal of the Medical Sciences·G M HillR D Dick
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·G A EbyW W Halcomb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.